May 17th, 2010

New Way RA Season 2 Premieres Today

From Megan Farina, Manager, Corporate Communications, Centocor Ortho Biotech Inc.

With the launch of New Way RATM last year, our hope was to offer support to people living with RA, as well as their caregivers. Over the past ten months, we’ve continued to learn from the RA social community through their posts as well as direct conversations with authors of blogs such as RA Warrior, All Flared Up, and Arthritis is a Journey. Listening to their insights helped us understand the deeper impact of contending with unpredictable and untimely flares of stiff, swollen and painful joints – we learned that participating in everyday activities with family & friends and maintaining relationships can quickly become overwhelming.

Because of their insights and honest feedback, New Way RATM has evolved from one pilot episode to a second season of episodes that will run year-long.

Today, we’re pleased to announce the premiere of Season 2 with a new mix of experts having candid discussions about personal style, dating, intimacy and the myths of RA. We’ve also expanded the format to include two panelists living with RA – author and RA advocate Amye Leong, and Sara Nash, the blogger behind the Single Gal’s Guide to Rheumatoid Arthritis.

Read More

May 14th, 2010

Battling the Obesity Epidemic in the Workplace

The following is from my friend and colleague, From Efrem Dlugacz who is Vice President Global Total Rewards & Health Resource.

Having worked for many years handling benefits for Johnson & Johnson, I can tell you that employee wellness and disease prevention is as important as to me as ensuring employees have access to different treatment options. For many years, we’ve been encouraging employees to develop healthy lifestyles, and one of the most pressing challenges we face is figuring out a way to address the impact that inactivity and obesity have on our workforce.

In that, of course, we aren’t alone. Did you know that about two-thirds of adults are overweight or obese in the US and the direct and indirect cost of obesity-associated conditions in the United States is estimated at nearly $80 billion a year? People who are overweight or obese are at a greater risk for developing diabetes, stroke, hypertension, high cholesterol and certain types of cancers – and for an employer, that can mean greater absenteeism and higher healthcare costs compared to non-obese employees.

But employers can help make a difference.

We’ve found that employees who are inactive, overweight or obese, benefit greatly from company sponsored programs that focus on healthy living, eating, and exercise.

Read More

May 10th, 2010

Twittering Along…

For more than a year now, I’ve been Tweeting on behalf of Johnson & Johnson over at @JNJComm and have found it to be a great way to meet and interact with new people, keep up with the latest news and be available when people have different questions about what we are doing as an organization.

Well, now I’m pleased to welcome a few of my colleagues to the Twittersphere. Over the last few days, my colleagues including Rob Halper, who is responsible for the Johnson & Johnson YouTube Channel, Margaret Gurowitz who writes the Kilmer House blog, Mark Krajnak, who is responsible for the corporate website (and a photographer extraordinaire) and fellow JNJBTW contributor Melissa Waggenspack, have set up their own Twitter accounts and are starting to Tweet.

Those accounts include:

@JNJStories – where Mark and Melissa will share stories about our company, our people, our partners, our patients and our customers.

@JNJvideo – where Rob Halper will be posting a variety of tweets that touch on his world of video content.

@JNJHistory – where Margaret will post about different historical facts, figure and stories

I, of course, will continue to Tweeting about different Johnson & Johnson-related news and events, announcements, interesting posts and content that’s been uploaded to our sites and other musings on stuff I find cool and interesting.

Read More

May 7th, 2010

To All Who Use Our Products — From Bill Weldon

I just wanted to share the following open letter from Chairman and Chief Executive Officer Bill Weldon about the recent recalls at our McNeil Consumer Healthcare company. He asked us to publish it by posting on JNJBTW:

To All Who Use Our Products,

We have a responsibility at Johnson & Johnson to provide you with the highest-quality products possible, and we have worked hard to fulfill that responsibility day-by-day for over a century.

The recent recalls of some over-the-counter medicines from our McNeil Consumer Healthcare operating company are a matter of great concern. They are a disappointment to me, and to the employees of the Johnson & Johnson Family of Companies. You can be confident that we will make whatever changes are needed at McNeil to fully restore the quality of its manufacturing.

As reported, McNeil has suspended all manufacturing operations at its facility in Fort Washington, Pa., until we can be sure that they are operating under the standards we demand of ourselves, and which our customers expect of us. McNeil has also retained independent quality experts to assist in this regard and is re-evaluating quality systems and manufacturing processes across the organization.

I have been assured that the chance of a serious medical event from the recalled products is remote.

Read More

May 4th, 2010

McNeil’s Response to Today’s News

Earlier today, the U.S. Food and Drug Administration issued a report describing manufacturing-related observations from inspections of the McNeil Consumer Healthcare facility at Fort Washington, PA related to the recent recall announcement and later held a press conference to go over their findings. In response, McNeil issued a public statement. You can read the entire statement, but I thought the following passage is important to note:

We have no higher concern than providing parents with the highest quality products for their children. The quality issues that the FDA has observed, many of which we had recently identified in our own quality reviews and communicated to the FDA, are unacceptable to us, and not indicative of how McNeil Consumer Healthcare intends to operate. While the chance of serious adverse medical reaction is remote, we apologize to those who rely on our medicines for the concern and inconvenience this recall may have caused. We will provide a detailed response to the FDA on their observations, and work diligently to ensure that they are addressed.

A complete list of the products involved and additional information about the recall can be found on their website, or by calling 1-888 222-6036.

Read More

May 1st, 2010

McNeil Announces Voluntary Recall

Last night, the McNeil Consumer Healthcare business of Johnson & Johnson announced the voluntary recall of certain lots of over-the-counter infants’ and children’s products. In their press release, the company said the following that explains why this is happening:

“McNeil Consumer Healthcare is initiating this voluntary recall because some of these products may not meet required quality standards. This recall is not being undertaken on the basis of adverse medical events. However, as a precautionary measure, parents and caregivers should not administer these products to their children. Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles. While the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use.”

A complete list of the products involved and additional information about the recall can be found on their website, or by calling 1-888 222-6036 (Monday-Friday 8 a.m. to 10 p.m. Eastern Time, and Saturday-Sunday 9 a.m. to 5 p.m. Eastern Time). Any adverse reactions may also be reported to the FDA’s MedWatch Program by fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at

Read More

April 23rd, 2010

Tweets from Today’s Shareholder Meeting

As I was wrapping everything up for the day, I thought that for those who weren’t following @JNJComm this morning ‘d share my tweets from today’s annual shareholders meeting. The meeting started at about 10 AM Eastern Standard Time.

10:04 — Johnson & Johnson Chairman and CEO Bill Weldon addresses shareholders at company’s annual meeting #JNJAM10

10:37 — CEO Weldon says 70% of sales are from products with #1 or #2 market share positions #JNJAM10

10:37 — CEO Weldon says it is the 48th consecutive year Johnson & Johnson has increased quarterly dividend #JNJAM10

10:38 — CEO Weldon says that in 2009, Johnson & Johnson delivered total shareholder return of 11.3 percent #JNJAM10

10:40 — Shareholders elect nominees to the J&J Board of Directors/ratify PricewaterhouseCoopers as independent auditors for 2010 #JNJAM10

10:41 — Johnson & Johnson increased quarterly dividend from 49 cents a share to 54 cents a share #JNJAM10

10:46 — CEO Weldon outlines 4 factors that enable growth that will be focused on: 1) innovative products, 2) robust pipelines #JNJAM10

10:47 — CEO Weldon outlines 4 factors that enable growth that will be focused on: 3) global presence, 4) talented people #JNJAM10

10:49 — WW Chairman of Consumer, Colleen Goggins addresses the Johnson & Johnson shareholder meeting #JNJAM10

10:50 — Goggins describes opportunities for the consumer business: emerging markets, digital media, non-traditional retail channels, sustainability

10:55 — Johnson & Johnson increased quarterly dividend from 49 cents a share to 54 cents a share #JNJAM10 $JNJ

11:03 — Goggins highlights Text4Baby initiative ( and at J&J shareholder meeting #JNJAM10

11:04 — WW Chairman of Medical Devices and Diagnostics Alex Gorsky addresses Johnson & Johnson shareholder meeting #JNJAM10

11:10 – Gorsky says MD&D segment is “largest in the world” and then highlights some of the breakthrough innovations the company is bring to market

11:19 — WW Chairman of Pharmaceuticals Sheri McCoy addresses Johnson & Johnson shareholder meeting #JNJAM10

11:23 — McCoy describes how the global pharmaceutical market is roughly $775 billion and projected to grow to over a trillion by 2014 #JNJAM10

11:39 — CEO Weldon describes the company’s Bridge to Employment program — and how it builds HC systems and lives #JNJAM10

11:42 — CEO Weldon talks about how Johnson & Johnson responded to the earthquake in Chile #JNJAM10

12:23 — That’s the end of the presentations at the J&J annual shareholders meeting.

Read More

April 22nd, 2010

Busy Day Here in New Brunswick… And an Earth Day Video to Boot

It has been a busy day — not only did Johnson & Johnson hold its yearly shareholders meeting (check out my Twitter stream on it – oh, and Margaret Gurowitz’s post on the history of the meeting) — but today was also Earth Day. It so happens, to commemorate the day Rob Halper uploaded a short video on the health channel about some of the green initiatives at our corporate headquarters building in New Brunswick, which was recently awarded LEED Existing Buildings Gold Certification from the U.S. Green Building Council. This award recognizes performance in key areas like water and energy efficiency, indoor environmental quality, materials used and wastes generated, and innovative design. Check it out:

Read More

April 21st, 2010

Partnering for a Healthier Future

From Tish Lascelle, Senior Director, Strategy and Assurance, Worldwide Environment, Health & Safety,
Johnson & Johnson

On Earth Day 2010, I’ll be thinking about the year 2015.

I work in an environmental and sustainability capacity for Johnson & Johnson, and during the past 12 months I’ve been stewarding the development of our next set of long-term sustainability goals: our Healthy Future 2015 goals.

When I was a kid I was inspired by Marie Curie. Learning about her was my first realization that women could be scientists – and, she did it in the early 1900’s! On top of that, she was cool because she discovered and named two elements, most notably radium – the early ‘glo’ in Day-Glo (yes, also a child of the 60’s). Madame Curie once said, “Nothing in life is to be feared. It is only to be understood. Now is the time to understand more.” Her words resonate with me today as I work with the team at Johnson & Johnson to understand more about our role in contributing to a healthier future. I believe our sustainability strategy is richer because we invite the views of our stakeholders.

Dialogue with external partners helps us to identify and understand emerging risks and opportunities in the sustainability space.

Read More

April 19th, 2010

40 Years of Earth Day

From Annette Russo, Manager, Communications and Training, WWEHS, Johnson & Johnson

Like twenty million other Americans, I was part of the first Earth Day on April 22, 1970. I heeded the call for a day of protest and education, and did a small thing to improve the environment. Looking back, I think my Earth Day experiences parallel the history of the day itself. As I eventually became a consultant and groundwater geologist, I understood the reasons for the growing number of environmental regulations. I became part of a growing cadre of environmental professionals trained to address environmental compliance and remediation. We learned to use environmental management systems as a tool for better environmental management.

And today, people take a holistic view of the environment – looking at the products companies make as well as the places where they make them while considering social and economic impacts alongside environmental ones. Many call this “sustainability”, and it has changed the way business gets done. 

It’s Earth Day 1970…I’m standing waist deep in a cold, spring-fed creek in my hometown pushing a wire box filled with heavy rock down into the mud of the creek bed. We’re trying to save the creek. The city moved it a few months earlier to build a new road, leaving a bed that was wide and shallow.

Read More